- Crinetics Pharmaceuticals (CRNX) priced an underwritten public offering of 7.62M shares at a price to the public of $45.95 per share.
- The gross proceeds to Crinetics from the offering are expected to be approximately $350M.
- The underwriters have a 30-day
Crinetics Pharmaceuticals prices offering at $45.95 per share (CRNX:NASDAQ)
